The Leibniz Institute for Plasma Science and Technology (INP Greifswald) is the largest non-university institute in the area of low temperature plasmas in Europe, including their basic research and technical applications. On the one hand, INP aims to carry out application-oriented basic research while on the other hand it aims to optimize and further develop established plasma-assisted procedures and plasma products. INP is capable of adapting plasmas to specific customer needs including services and consultations, completed by preliminary and feasibility studies. INP launches research projects starting with the concept right through to building prototypes with market needs.
Current top priorities are materials and energy as well as interdisciplinary topics in environment and health, specially-designed plasma sources, plasma modelling and diagnostics.
INP has not only 3,700 sqm main floor space, but also 41 laboratories, a classified clean room and a microbiological laboratory. In 2010 a new building with additional 540 sqm and 8 new laboratories was opened for interdisciplinary research. INP is organized as a non-profit organization employing 183 co-workers. Its total annual budget is approximately 15.8 million €. About 6.4 million € of total annual budget are competitively acquired third-party funds from the industry, German Research Foundation (DFG), Federal Ministry of Education and Research (BMBF) or European Union.
To close the gap between a first idea in the lab and the successful product launch on the market, INP established three spin-offs.
The neoplas GmbH transfer centre of the INP was founded in 2005. neoplas puts its emphasis on utilization and valorization of research results for industrial applications with the objective of economic success.
The neoplas control GmbH, launched in 2006, is part of the neoplas group and produces and distributes q-macs (Quantum cascade laser Measurement And Control Systems) worldwide for the analysis of plasma processes or for highly sensitive trace gas analysis.
Founded in 2009, neoplas tools GmbH deals with the processing, manufacturing and the distribution of plasma sources for clinical applications.